{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:37:26Z","timestamp":1787949446211,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jad.2019.06.040","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T01:36:16Z","timestamp":1561944976000},"page":"509-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study\u2730"],"prefix":"10.1016","volume":"256","author":[{"given":"Angela","family":"Carlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna G.","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Rozing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sienaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Eikelenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Veerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max L.","family":"Stek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Rhebergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Dols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric van","family":"Exel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.06.040_bib0001","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0953-6205(02)00132-2","article-title":"C-reactive protein: history and revival","volume":"13","author":"Ablij","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jad.2019.06.040_bib0002","unstructured":"American Psychiatric Association, A.P.A., 2000. Diagnostic and statistical manual of mental disorders. American Psychiatric Press, Washington DC."},{"key":"10.1016\/j.jad.2019.06.040_bib0003","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.jad.2019.06.040_bib0004","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.metabol.2004.01.013","article-title":"Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease","volume":"53","author":"Browning","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.jad.2019.06.040_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2012.10.036","article-title":"Lack of clinical therapeutic benefit of antidepressants is associated with overall activation of the inflammatory system","volume":"148","author":"Carvalho","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.06.040_bib0006","first-page":"1","article-title":"Treatment-resistant depression and peripheral C-reactive protein","author":"Chamberlain","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.03.039","article-title":"ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules","volume":"138","author":"Charlson","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.06.040_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull"},{"key":"10.1016\/j.jad.2019.06.040_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand? Brain","volume":"15","author":"Dantzer","year":"2001","journal-title":"Behav. Immun."},{"key":"10.1016\/j.jad.2019.06.040_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jagp.2016.09.005","article-title":"Early- and late-onset depression in late Life: a prospective study on clinical and structural brain characteristics and response to electroconvulsive therapy","volume":"25","author":"Dols","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0011","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MOP.0000000000000492","article-title":"Febrile infant update","volume":"29","author":"Dorney","year":"2017","journal-title":"Curr. Opin. Pediatr"},{"key":"10.1016\/j.jad.2019.06.040_bib0012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/npp.2017.231","article-title":"Effort but not reward sensitivity is altered by acute sickness induced by experimental endotoxemia in humans","volume":"43","author":"Draper","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2019.06.040_bib0014","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jad.2010.11.035","article-title":"Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder","volume":"131","author":"Fluitman","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.06.040_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpsychires.2017.05.004","article-title":"The association of electroconvulsive therapy to pharmacological treatment and its influence on cytokines","volume":"92","author":"Freire","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.06.040_bib0016","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1002\/gps.4645","article-title":"Depression with inflammation: longitudinal analysis of a proposed depressive subtype in community dwelling older adults","volume":"32","author":"Gallagher","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0017","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archpsyc.60.10.1009","article-title":"Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults","volume":"60","author":"Glaser","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2014.08.004","article-title":"Clinical characteristics of inflammation-associated depression: monocyte gene expression is age-related in major depressive disorder","volume":"44","author":"Grosse","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jad.2019.06.040_bib0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/YCT.0000000000000127","article-title":"The immune system and electroconvulsive therapy for depression","volume":"30","author":"Guloksuz","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2019.06.040_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jad.2019.06.040_bib0021","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.medmal.2014.01.002","article-title":"Biomarkers and infection in the emergency unit","volume":"44","author":"Hausfater","year":"2014","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.jad.2019.06.040_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","article-title":"Defining remission by cut off score on the MADRS: selecting the optimal value","volume":"72","author":"Hawley","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.06.040_bib0024","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.06.040_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00124509-200312000-00002","article-title":"Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy","volume":"19","author":"Hestad","year":"2003","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2019.06.040_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2019.06.040_bib0027","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/0269881117725711","article-title":"Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis","volume":"31","author":"Husain","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.06.040_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/acps.12665","article-title":"Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression","volume":"135","author":"J\u00e4rventausta","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2019.06.040_bib0029","doi-asserted-by":"crossref","first-page":"w13880","DOI":"10.4414\/smw.2014.13880","article-title":"Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study","volume":"144","author":"Kargar","year":"2014","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jad.2019.06.040_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2006.09.033","article-title":"Sustained low-grade Pro-inflammatory state in Unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid a","volume":"62","author":"Kling","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0031","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0032","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15622975.2017.1355473","article-title":"Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression","volume":"19","author":"Kranaster","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0033","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11597","article-title":"Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression","volume":"79","author":"Kruse","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0034","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000482001","article-title":"Depression in the context of medical disorders: new pharmacological pathways revisited","volume":"25","author":"Lang","year":"2017","journal-title":"NeuroSignals"},{"key":"10.1016\/j.jad.2019.06.040_bib0035","doi-asserted-by":"crossref","first-page":"198s","DOI":"10.1016\/S0924-9338(99)80239-9","article-title":"The mini international neuropsychiatric interview","volume":"13","author":"Lecrubier","year":"1998","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0036","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/ijms17122022","article-title":"Peripheral inflammatory parameters in late-life depression: a systematic review","volume":"17","author":"Mart\u00ednez-Cengotitabengoa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2019.06.040_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jad.2019.06.040_bib0038","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.55095\/achot2015\/054","article-title":"C-reactive protein in orthopaedic surgery","volume":"82","author":"Neumaier","year":"2015","journal-title":"Acta Chir. Orthop. Traumatol. Cech."},{"key":"10.1016\/j.jad.2019.06.040_bib0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo major depression","volume":"197","author":"Pasco","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0041","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2019.06.040_bib0042","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7015-11-129","article-title":"Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile","volume":"11","author":"Penninx","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jad.2019.06.040_bib0043","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","article-title":"C-reactive protein: a valuable marker of sepsis","volume":"28","author":"P\u00f3voa","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jad.2019.06.040_bib0044","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0046","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0047","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jad.2019.06.040_bib0048","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0049","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2016.06.035","article-title":"Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy","volume":"205","author":"Rush","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.06.040_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exger.2017.12.005","article-title":"The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis","volume":"102","author":"Smith","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jad.2019.06.040_bib0051","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbi.2009.04.011","article-title":"A prospective evaluation of the directionality of the depression-inflammation relationship","volume":"23","author":"Stewart","year":"2009","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jad.2019.06.040_bib0052","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.06.040_bib0053","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2019.06.040_bib0054","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect. Disord"},{"key":"10.1016\/j.jad.2019.06.040_bib0055","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1038\/tp.2015.100","article-title":"Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?","volume":"5","author":"van Buel","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0056","series-title":"Nederlandse Vereniging voor Psychiatrie","first-page":"36","article-title":"Guideline electroconvulsive therapy [Richtlijn elektroconvulsietherapie]","author":"van den Broek","year":"2010"},{"key":"10.1016\/j.jad.2019.06.040_bib0057","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis","volume":"212","author":"Van Diermen","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbi.2016.05.006","article-title":"Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: a randomised controlled study","volume":"57","author":"Vinberg","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jad.2019.06.040_bib0059","first-page":"362","article-title":"Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review","volume":"157","author":"Watt","year":"2015","journal-title":"Surg. (United States)"},{"key":"10.1016\/j.jad.2019.06.040_bib0060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM200504143521525","article-title":"Distribution of C-reactive protein values in the United States","volume":"352","author":"Woloshin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2019.06.040_bib0061","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.06.040_bib0062","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","article-title":"Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review","volume":"11","author":"Yrondi","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1016\/j.jad.2019.06.040_bib0063","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00213-015-3919-9","article-title":"Low-grade inflammation predicts persistence of depressive symptoms","volume":"233","author":"Zalli","year":"2016","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:33:05Z","timestamp":1759023185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719302150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":63,"alternative-id":["S0165032719302150"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.06.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study\u2730","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}